Posted by Brian Wu on Nov 19th, 2024
Dianthus Therapeutics, Inc. (NASDAQ:DNTH – Get Free Report) saw a significant growth in short interest in October. As of October 31st, there was short interest totalling 5,100,000 shares, a growth of 7.8% from the October 15th...
More of this article »